Evidence map›Paper›PMID 25690012›Full record

ArticleScience signaling2015

A molecular signature in the pannexin1 intracellular loop confers channel activation by the α1 adrenoreceptor in smooth muscle cells.

Marie Billaud, Yu-Hsin Chiu, Alexander W Lohman, Thibaud Parpaite, Joshua T Butcher, Stephanie M Mutchler, Leon J DeLalio, Mykhaylo V Artamonov, Joanna K Sandilos, Angela K Best and 6 more

Abstract read
In one paragraph

Article in Science signaling, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 140 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Pannexins in the vasculature.American journal of physiology. Heart and circulatory physiology · 2025
    Review
  5. Pannexin channels in the kidney.American journal of physiology. Renal physiology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. The C-terminal activating domain promotes pannexin 1 channel opening.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  11. Article
  12. The C-terminal activating domain promotes Panx1 channel opening.bioRxiv : the preprint server for biology · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Structure-Based Design and Synthesis of StapledJournal of medicinal chemistry · 2023
    Article
  19. Article
  20. Pharmacology of pannexin channels.Current opinion in pharmacology · 2023
    Review

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Marie BillaudRobert M. Berne Cardiovascular Research Center, University of Virginia School of Medicine, Charlottesville, VA 22908, USA. Department of Molecular Physiology and Biophysics, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Yu-Hsin ChiuDepartment of Pharmacology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Alexander W LohmanRobert M. Berne Cardiovascular Research Center, University of Virginia School of Medicine, Charlottesville, VA 22908, USA. Department of Molecular Physiology and Biophysics, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Thibaud ParpaiteRobert M. Berne Cardiovascular Research Center, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Joshua T ButcherRobert M. Berne Cardiovascular Research Center, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Stephanie M MutchlerRobert M. Berne Cardiovascular Research Center, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Leon J DeLalioRobert M. Berne Cardiovascular Research Center, University of Virginia School of Medicine, Charlottesville, VA 22908, USA. Department of Molecular Physiology and Biophysics, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Mykhaylo V ArtamonovDepartment of Molecular Physiology and Biophysics, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Joanna K SandilosDepartment of Pharmacology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Angela K BestRobert M. Berne Cardiovascular Research Center, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Avril V SomlyoRobert M. Berne Cardiovascular Research Center, University of Virginia School of Medicine, Charlottesville, VA 22908, USA. Department of Molecular Physiology and Biophysics, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Roger J ThompsonDepartment of Cell Biology and Anatomy, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta T2N 4N1, Canada.
Thu H LeDepartment of Medicine, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Kodi S RavichandranCenter for Cell Clearance, University of Virginia, Charlottesville, VA 22908, USA. Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA. Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA 22908, USA.
Douglas A BaylissDepartment of Pharmacology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Brant E IsaksonRobert M. Berne Cardiovascular Research Center, University of Virginia School of Medicine, Charlottesville, VA 22908, USA. Department of Molecular Physiology and Biophysics, University of Virginia School of Medicine, Charlottesville, VA 22908, USA. brant@virginia.edu.
University of Virginia · USCarter Center · USUniversity of Calgary · CA

Funding

Women's Oncology Program - WONP30CA044579 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Thomas P. Loughran · 1987 to 2026
$72.1M
Role of Pannexins in Vascular Smooth Muscle CellsP01HL120840 · NHLBI · UNIVERSITY OF VIRGINIA · PI BAYLISS, DOUGLAS A., RAVICHANDRAN, KODI S · 2014 to 2023
$24.0M
BASIC CARDIOVASCULAR RESEARCH TRAINING GRANTT32HL007284 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Brant E Isakson, Gary K Owens · 1985 to 2026
$19.6M
Molecular Mechanisms of RhoA-mediated Ca2+Sensitization in Vascular Smooth MuscleR01GM086457 · NIGMS · UNIVERSITY OF VIRGINIA · PI DEREWENDA, URSZULA, DEREWENDA, ZYGMUNT S · 2009 to 2017
$5.4M
Mechanisms of Heterocellular Signaling at the Myoenothelial JunctionR01HL088554 · NHLBI · UNIVERSITY OF VIRGINIA · PI ISAKSON, BRANT E, WEISS, MITCHELL J · 2008 to 2017
$3.8M
GSTM1, APOL1, and their joint contribution to severity of hypertension and chronic kidney diseaseR01DK094907 · NIDDK · UNIVERSITY OF VIRGINIA · PI LE, THU H., MYCHALECKYJ, JOSYF · 2012 to 2021
$1.7M
Angiopathy Training GrantT32HL094295 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MARS, WENDY MICHELLE · 2010 to 2014
$1.2M
Release of find-me signals during apoptotic cell clearanceR01GM107848 · NIGMS · UNIVERSITY OF VIRGINIA · PI BAYLISS, DOUGLAS A., RAVICHANDRAN, KODI S · 2013 to 2016
$1.2M
Myosin phosphatase autoinhibition in gastrointestinal smooth muscle contractionR01DK088905 · NIDDK · UNIVERSITY OF VIRGINIA · PI ETO, MASUMI, SOMLYO, AVRIL V. · 2010 to 2012
$1.1M
NCI NIH HHS P30 CA044579NHLBI NIH HHS HL007284NHLBI NIH HHS HL088554NHLBI NIH HHS P01 HL120840NHLBI NIH HHS R01 HL088554NHLBI NIH HHS T32 HL007284NHLBI NIH HHS T32 HL094295NIDDK NIH HHS DK094907NIDDK NIH HHS R01 DK088905NIDDK NIH HHS R01DK088905NIDDK NIH HHS R01 DK094907NIGMS NIH HHS GM086457NIGMS NIH HHS GM107848NIGMS NIH HHS R01 GM086457NIGMS NIH HHS R01 GM107848
6 · The paper itself

Abstract

Both purinergic signaling through nucleotides such as ATP (adenosine 5'-triphosphate) and noradrenergic signaling through molecules such as norepinephrine regulate vascular tone and blood pressure. Pannexin1 (Panx1), which forms large-pore, ATP-releasing channels, is present in vascular smooth muscle cells in peripheral blood vessels and participates in noradrenergic responses. Using pharmacological approaches and mice conditionally lacking Panx1 in smooth muscle cells, we found that Panx1 contributed to vasoconstriction mediated by the α1 adrenoreceptor (α1AR), whereas vasoconstriction in response to serotonin or endothelin-1 was independent of Panx1. Analysis of the Panx1-deficient mice showed that Panx1 contributed to blood pressure regulation especially during the night cycle when sympathetic nervous activity is highest. Using mimetic peptides and site-directed mutagenesis, we identified a specific amino acid sequence in the Panx1 intracellular loop that is essential for activation by α1AR signaling. Collectively, these data describe a specific link between noradrenergic and purinergic signaling in blood pressure homeostasis.

Indexed as

Adenosine TriphosphateAmino Acid SequenceAnalysis of VarianceAnimalsBlood PressureBlotting, WesternConnexinsEndothelin-1Fluorescent Antibody TechniqueHEK293 CellsHumansMiceMice, Inbred C57BLMolecular Sequence DataMuscle, Smooth, VascularMutagenesis, Site-DirectedAdenosine TriphosphateConnexinsEndothelin-1Nerve Tissue ProteinsPanx1 protein, mouseReceptors, Adrenergic, alpha-1Serotonin

Identifiers

PMID25690012
PMCPMC4358815
OpenAlexW2150612042

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.